BioMedInformatics, Volume 4, Issue 3
2024 September - 26 articles
Cover Story: In modern cancer genomics, panels analyze ~500 genes, although the human genome has 20,000. While whole genome sequencing (WGS) now costs ~$1,000, interpreting vast data remains a challenge. If tumor panels fail to identify actionable genes, extra genomic data may not aid in treatment decisions. However, advances in ML and DL architectures offer new insights. AI has enabled progress in fields such as Radiomics, Pathomics, and Surgomics, integrating them with WGS to create AI-augmented tumor boards, improving treatment by minimizing ineffective therapies. Advanced imaging also aids in surgical decisions. AI-driven multi-omics integration—the combination of genomics, transcriptomics, and proteomics—promises better diagnosis and treatment, with deep learning poised to revolutionize biomarker identification. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.